Literature DB >> 21107108

Factors predicting the quality of total mesorectal excision for rectal cancer.

Daniel Leonard1, Freddy Penninckx, Steffen Fieuws, Anne Jouret-Mourin, Christine Sempoux, Constant Jehaes, Elizabeth Van Eycken.   

Abstract

OBJECTIVE: To determine preoperative tumor-, patient-, and treatment-related factors that are independently associated with incomplete mesorectal excision. SUMMARY OF BACKGROUND DATA: Incomplete total mesorectal excision (TME) for rectal cancer is associated with increased local and overall recurrences. Factors predicting incomplete mesorectal excision have scarcely been studied.
METHODS: In the context of PROCARE, a Belgian multidisciplinary project on rectal cancer, the quality of 266 consecutive and anonymized TME specimens submitted by 33 candidate-TME-trainers was graded by a blinded pathology review board in a standardized manner. Uni- and multivariable analysis were performed to identify factors that can independently predict incomplete mesorectal excision.
RESULTS: Mesorectal resection was complete in 21%, nearly complete in 47%, and incomplete in 32%. Of 57% of TME specimens the grade of resection had not been reported by the local pathologist. Incomplete TME doubled the incidence of a positive circumferential resection margin (P = 0.004). Factors found to be significantly related to incomplete TME in univariate analysis were as follows: surgeon, female gender, pathologic body mass index, low rectal cancer, negative clinical nodal status, the absence of downstaging after long-course chemoradiation, laparoscopic and converted laparoscopic resection, and abdominoperineal resection. Multivariable analysis identified pathologic body mass index (P = 0.017), the absence of downstaging after long-course chemoradiation (P = 0.0005), and laparoscopic or converted laparoscopic resection (P = 0.014) as factors that are independently associated with incomplete mesorectal excision.
CONCLUSION: Good TME quality cannot be guaranteed. This peer-reviewed TME assessment revealed a number of factors that are independently related to incomplete TME. Both specimen and pathology report need to be audited.

Entities:  

Mesh:

Year:  2010        PMID: 21107108     DOI: 10.1097/SLA.0b013e3181efc142

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  Transanal Total Mesorectal Excision for Treatment of Carcinoma in the Middle or Lower Third Rectum: the Technical Feasibility of the Procedure, Pathological Results, and Clinical Outcome.

Authors:  Ashraf M Abdelkader; Ahmed M Zidan; Mohamed T Younis; Shaimaa K Dawa
Journal:  Indian J Surg Oncol       Date:  2018-08-04

2.  Predicting the pathological features of the mesorectum before the laparoscopic approach to rectal cancer.

Authors:  Sonia Fernández Ananín; Eduardo M Targarona; Carmen Martinez; Juan Carlos Pernas; Diana Hernández; Ignasi Gich; Francesc J Sancho; Manuel Trias
Journal:  Surg Endosc       Date:  2014-06-21       Impact factor: 4.584

3.  Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database.

Authors:  Eisar Al-Sukhni; Kristopher Attwood; Emmanuel Gabriel; Steven J Nurkin
Journal:  Int J Surg       Date:  2016-02-21       Impact factor: 6.071

4.  European Association of Endoscopic Surgeons (EAES) consensus statement on the use of robotics in general surgery.

Authors:  Amir Szold; Roberto Bergamaschi; Ivo Broeders; Jenny Dankelman; Antonello Forgione; Thomas Langø; Andreas Melzer; Yoav Mintz; Salvador Morales-Conde; Michael Rhodes; Richard Satava; Chung-Ngai Tang; Ramon Vilallonga
Journal:  Surg Endosc       Date:  2014-11-08       Impact factor: 4.584

5.  The new approach to the rectal cancer: 'down-to-up' double endolaparoscopic pelvic access. Preliminary evaluation of outcomes.

Authors:  Dario Borreca; Alberto Bona; Maria Paola Bellomo; Andrea Borasi; Paolo De Paolis
Journal:  Updates Surg       Date:  2015-06-25

6.  CT/MRI pelvimetry as a useful tool when selecting patients with rectal cancer for transanal total mesorectal excision.

Authors:  Alexander Ferko; Ondřej Malý; Július Örhalmi; Josef Dolejš
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

7.  Is laparoscopic surgery really effective for the treatment of colon and rectal cancer in very elderly over 80 years old? A prospective multicentric case-control assessment.

Authors:  Francesco Roscio; Luigi Boni; Federico Clerici; Paolo Frattini; Elisa Cassinotti; Ildo Scandroglio
Journal:  Surg Endosc       Date:  2016-02-19       Impact factor: 4.584

8.  Oncological outcomes and stoma-free survival following TaTME, a prospective cohort study.

Authors:  S Hallam; F Ahmed; N Gouvas; S Pandey; D Nicol
Journal:  Tech Coloproctol       Date:  2021-02-19       Impact factor: 3.781

9.  Robotic versus laparoscopic coloanal anastomosis with or without intersphincteric resection for rectal cancer.

Authors:  Se Jin Baek; Sami Al-Asari; Duck Hyoun Jeong; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Nam Kyu Kim
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

10.  Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid-low rectal cancer.

Authors:  Gulsen Atasoy; Naciye Cigdem Arslan; Funda Dinc Elibol; Ozgul Sagol; Funda Obuz; Selman Sokmen
Journal:  Surg Today       Date:  2018-06-30       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.